NTLA - Intellia Therapeutics, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	Qty	oc	Own	H
10/4/24 17:29	10/2/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Dube Michael P	MA	O	VP,Chief	S	-38	19.01	-2	-4	47	D
7/3/24 13:15	7/1/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Clark Eliana	MA	O	EVP,Chie	S	-9	22.93	0	-1	71	D
6/20/24 17:00	6/17/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Verwiel Frank	MA	D		S	-38	25.00	-2	-8	18	D
3/5/24 16:10	3/4/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Basta James	MA	O	EVP,GC	S.d	-76	32.99	-2	-3	82	D
3/5/24 16:10	3/4/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Clark Eliana	MA	O	EVP,Chie	S.d	-20	32.99	-1	-1	71	D
1/10/24 16:15	1/8/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Sepp-Lorenzino Laura	MA	O	EVP,Chie	S	-66	28.87	-2	-5	44	D
1/5/24 16:51	1/3/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Leonard John M	MA	DO	P,CEO	S	-566	29.46	-19	-2	905	D
1/5/24 16:50	1/3/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Lebwohl David	MA	O	EVP,Chie	S	-172	29.46	-6	-10	54	D
1/5/24 16:50	1/3/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Sepp-Lorenzino Laura	MA	O	EVP,Chie	S	-163	29.46	-6	-11	46	D
1/5/24 16:49	1/3/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Goddard Glenn	MA	O	EVP,CFO	S	-158	29.46	-5	-12	41	D
1/5/24 16:46	1/3/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Hicks Derek	MA	O	EVP,Chie	S	-114	29.46	-4	-9	37	D
1/5/24 16:45	1/3/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Basta James	MA	O	EVP,GC	S	-112	29.46	-4	-7	51	D
1/5/24 16:44	1/3/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Clark Eliana	MA	O	EVP,Chie	S	-136	29.50	-5	-10	41	D
1/3/24 17:35	1/1/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Sepp-Lorenzino Laura	MA	O	EVP,Chie	M.d	0	0.00	4	7	52	D
1/3/24 17:34	1/1/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Lebwohl David	MA	O	EVP,Chie	M.d	0	0.00	3	6	60	D
1/3/24 17:30	1/1/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Leonard John M	MA	DO	P,CEO	M.d	0	0.00	8	1	924	D
1/3/24 17:28	1/1/24	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Goddard Glenn	MA	O	EVP,CFO	M.d	0	0.00	3	7	46	D
11/2/23 16:42	10/31/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Bhanji Muna	MA	D		S	-6	23.90	0	-2	12	D
8/2/23 17:19	7/31/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Bhanji Muna	MA	D		S	-11	42.33	0	-2	12	D
7/10/23 17:21	7/6/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Bhanji Muna	MA	D		S	-73	39.30	-2	-13	13	D
7/6/23 15:34	7/3/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Clark Eliana	MA	O	EVP,Chie	S	-15	40.51	0	-1	45	D
6/22/23 17:52	6/20/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Clark Eliana	MA	O	EVP,Chie	M.d	61	12.27	5	12	45	D
6/22/23 17:52	6/20/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Clark Eliana	MA	O	EVP,Chie	S.d	-225	45.00	-5	-10	45	D
3/3/23 17:10	3/2/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Basta James	MA	O	EVP,GC	S.d	-48	43.88	-1	-2	55	D
1/6/23 17:39	1/4/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Sepp-Lorenzino Laura	MA	O	EVP,Chie	S.m	-183	37.82	-5	-22	18	D
1/6/23 17:32	1/4/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Leonard John M	MA	DO	P,CEO	S	-248	37.21	-7	-1	825	D
1/6/23 17:29	1/4/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Hicks Derek	MA	O	EVP,Chie	S	-67	37.21	-2	-9	17	D
1/6/23 17:26	1/4/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Lebwohl David	MA	O	EVP,Chie	S	-96	37.21	-3	-9	26	D
1/6/23 17:23	1/4/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Goddard Glenn	MA	O	EVP,CFO	S	-90	37.21	-2	-14	15	D
1/6/23 17:21	7/1/22	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Clark Eliana	MA	O	EVP,Chie	S.m	-76	37.65	-2	-12	14	D
1/6/23 17:19	1/4/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Basta James	MA	O	EVP,GC	S	-42	37.21	-1	-5	20	D
1/4/23 20:38	1/1/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Sepp-Lorenzino Laura	MA	O	EVP,Chie	M.d	0	0.00	4	18	22	D
1/4/23 20:36	1/1/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Leonard John M	MA	DO	P,CEO	M.d	0	0.00	8	1	832	D
1/4/23 20:33	1/1/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Lebwohl David	MA	O	EVP,Chie	M.d	0	0.00	3	13	28	D
1/4/23 20:29	1/1/23	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Goddard Glenn	MA	O	EVP,CFO	M.d	0	0.00	3	21	18	D
3/4/22 21:07	1/1/22	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Leonard John M	MA	DO	P,CEO	M.d	0	0.00	8	1	824	D
3/4/22 21:07	1/1/22	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Leonard John M	MA	DO	P,CEO	S.d	-280	112.26	-2	0	824	D
3/3/22 20:03	1/1/22	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Sepp-Lorenzino Laura	MA	O	EVP,Chie	M.d	0	0.00	4	23	19	D
3/3/22 20:03	1/1/22	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Sepp-Lorenzino Laura	MA	O	EVP,Chie	S.d	-129	112.25	-1	-6	19	D
3/3/22 20:00	1/1/22	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Lebwohl David	MA	O	EVP,Chie	M.d	0	0.00	3	15	25	D
3/3/22 20:00	1/1/22	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Lebwohl David	MA	O	EVP,Chie	S.d	-118	112.24	-1	-4	25	D
3/3/22 19:38	1/1/22	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Goddard Glenn	MA	O	EVP,CFO	M.d	0	0.00	3	26	15	D
3/3/22 19:38	1/1/22	NTLA	Health	Diagn	In Vitro & In Vivo Diagnostic	Goddard Glenn	MA	O	EVP,CFO	S.d	-114	112.24	-1	-6	15	D

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y